Study Finds All Major Pharmaceutical Companies Implicated in Bribery Schemes
A study published in February 2026 in the Journal of Law, Medicine & Ethics is the first to compile decades of Organization for Economic Cooperation and Development (OECD) enforcement records into a single analysis. Researchers Kohler, Khan, and Bowra reviewed OECD Working Group on Bribery reports from 1999 through early 2025 and found that virtually […]
Cancer Treatments Using mRNA Technology Targeted as COVID Shots Sales Decline
BioNTech SE and Moderna, Inc., two leading pharmaceutical companies that developed the mRNA COVID-19 biological, are facing new financial and regulatory challenges as demand for COVID booster shots continues to fall and U.S. health policy changes reshape the vaccine market.1 Moderna cut its 2025 sales forecast to between $1.5 billion and $2.2 billion, down as […]
‘All New Vaccines’ in the U.S. to Undergo Placebo-Controlled Safety Testing
On Apr. 30, 2025, the U.S. Department of Health and Human Services (DHHS) announced that all newly developed vaccines will now be required to undergo placebo-controlled clinical trials before being licensed by the U.S. Food and Drug Administration (FDA). This landmark policy shift comes after years of advocacy from consumer organizations critical of vaccine safety […]
Pfizer Accused of Largest Tax Dodging Scheme in Pharmaceutical Industry History
Pfizer, Inc. has been accused of engaging in the largest tax dodging scheme in pharmaceutical history. After a four-year investigation into pharmaceutical companies purported abuse of 2017 tax breaks, Democratic members of Congress have uncovered unprecedented corruption. Senator Ron Wyden of Oregon recently stated that Pfizer allegedly “carried out what could be the largest tax-dodging […]